7.47
전일 마감가:
$7.25
열려 있는:
$7.25
하루 거래량:
2.57M
Relative Volume:
0.36
시가총액:
$1.31B
수익:
$2.59B
순이익/손실:
$-981.73M
주가수익비율:
-1.2946
EPS:
-5.77
순현금흐름:
$206.95M
1주 성능:
+4.99%
1개월 성능:
+8.19%
6개월 성능:
-18.95%
1년 성능:
-42.13%
텔라닥 헬스 Stock (TDOC) Company Profile
명칭
Teladoc Health Inc
전화
(203) 635-2002
주소
2 MANHATTANVILLE ROAD, PURCHASE, NY
TDOC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
TDOC
Teladoc Health Inc
|
7.458 | 1.24B | 2.59B | -981.73M | 206.95M | -5.77 |
![]()
VEEV
Veeva Systems Inc
|
242.81 | 39.03B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
TEM
Tempus Ai Inc
|
64.71 | 11.29B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
98.36 | 7.90B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
DOCS
Doximity Inc
|
52.40 | 11.14B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
WAY
Waystar Holding Corp
|
39.55 | 7.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
텔라닥 헬스 Stock (TDOC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-11-15 | 개시 | Goldman | Buy |
2024-09-17 | 재확인 | Jefferies | Hold |
2024-02-29 | 개시 | Cantor Fitzgerald | Overweight |
2024-02-26 | 개시 | Leerink Partners | Market Perform |
2024-01-17 | 다운그레이드 | DA Davidson | Buy → Neutral |
2024-01-03 | 개시 | Barclays | Overweight |
2023-04-12 | 개시 | Stephens | Equal-Weight |
2023-02-23 | 업그레이드 | SVB Securities | Market Perform → Outperform |
2022-10-24 | 업그레이드 | Guggenheim | Sell → Neutral |
2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
2022-09-07 | 개시 | Truist | Hold |
2022-08-17 | 다운그레이드 | Guggenheim | Neutral → Sell |
2022-08-12 | 개시 | DA Davidson | Buy |
2022-08-02 | 다운그레이드 | Berenberg | Buy → Hold |
2022-08-02 | 다운그레이드 | Cowen | Outperform → Market Perform |
2022-07-28 | 다운그레이드 | Goldman | Buy → Neutral |
2022-07-28 | 다운그레이드 | Needham | Buy → Hold |
2022-07-06 | 재확인 | BofA Securities | Neutral |
2022-05-05 | 다운그레이드 | Argus | Buy → Hold |
2022-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-04-28 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2022-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
2022-04-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2022-04-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2022-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-04-28 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2022-04-07 | 개시 | Guggenheim | Buy |
2022-04-01 | 재개 | Credit Suisse | Outperform |
2022-03-03 | 업그레이드 | Argus | Hold → Buy |
2022-02-23 | 재확인 | BofA Securities | Neutral |
2022-02-23 | 재확인 | Craig Hallum | Hold |
2022-02-23 | 재확인 | Evercore ISI | In-line |
2022-02-23 | 재확인 | Goldman | Buy |
2022-02-23 | 재확인 | JP Morgan | Overweight |
2022-02-23 | 재확인 | KeyBanc Capital Markets | Overweight |
2022-02-23 | 재확인 | Needham | Buy |
2022-02-23 | 재확인 | Oppenheimer | Outperform |
2022-02-23 | 재확인 | Stifel | Hold |
2022-02-11 | 개시 | Goldman | Buy |
2022-02-08 | 재확인 | Piper Sandler | Overweight |
2021-12-02 | 재개 | Jefferies | Hold |
2021-11-22 | 다운그레이드 | BTIG Research | Buy → Neutral |
2021-10-28 | 재확인 | Barclays | Equal Weight |
2021-10-28 | 재확인 | BofA Securities | Neutral |
2021-10-28 | 재확인 | Canaccord Genuity | Buy |
2021-10-28 | 재확인 | Citigroup | Buy |
2021-10-28 | 재확인 | Craig Hallum | Hold |
2021-10-28 | 재확인 | Needham | Buy |
2021-10-28 | 재확인 | Oppenheimer | Outperform |
2021-10-28 | 재확인 | Piper Sandler | Overweight |
2021-10-28 | 재확인 | UBS | Neutral |
2021-10-19 | 개시 | Wells Fargo | Overweight |
2021-08-02 | 다운그레이드 | Argus | Buy → Hold |
2021-07-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2021-05-28 | 개시 | Robert W. Baird | Neutral |
2021-04-15 | 개시 | Needham | Buy |
2021-01-07 | 개시 | BTIG Research | Buy |
2020-12-22 | 개시 | Evercore ISI | In-line |
2020-12-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
2020-12-04 | 개시 | Goldman | Neutral |
2020-11-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2020-09-22 | 개시 | DA Davidson | Buy |
2020-09-02 | 업그레이드 | Berenberg | Hold → Buy |
2020-08-17 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2020-07-14 | 개시 | Citigroup | Buy |
2020-07-13 | 개시 | Argus | Buy |
2020-07-07 | 개시 | Stephens | Overweight |
2020-04-30 | 재확인 | KeyBanc Capital Markets | Overweight |
2020-04-13 | 개시 | SVB Leerink | Outperform |
2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
2020-03-25 | 다운그레이드 | Craig Hallum | Buy → Hold |
2020-03-16 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2020-02-28 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2020-01-10 | 개시 | UBS | Neutral |
2020-01-09 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
텔라닥 헬스 주식(TDOC)의 최신 뉴스
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now? - TradingView
Current and Future Analysis of Virtual Care Platforms Market - openPR.com
Robust Growth in Digital Health Services Market (2025-2032): - openPR.com
Future Scope of Virtual Healthcare Services Market to Observe - openPR.com
Online Doctor Consultation Market: Trends, Growth, & Future - openPR.com
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid - AOL.com
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid - The Motley Fool
Robust Growth in Telemedicine Service Platform Market - openPR.com
TDOC Q1 Earnings Call: UpLift Acquisition and Integrated Care Growth Shape Teladoc’s Outlook - Yahoo Finance
Teladoc Health (NYSE:TDOC) Reports Q1 2025 Net Loss Of US$93 Million - Yahoo Finance
Telemedicine Market is Projected to grow at a CAGR of 16.8% - openPR.com
(TDOC) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit - MSN
Digital health companies faced a rocky start to 2025 - Modern Healthcare
Teladoc Health, Inc. (TDOC): Among the Best Growth Stocks Under $10 to Buy Right Now - Insider Monkey
Teladoc Health (TDOC) Price Target Lowered by Wells Fargo | TDOC Stock News - GuruFocus
Digital Health Market Generated Opportunities, Future Scope - openPR.com
ATA Nexus: Telehealth companies unite to change nutrition policy, bolstered by MAHA momentum - Fierce Healthcare
Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare - Quantisnow
Digital Healthcare Market Booms with AI Integration and Telehealth Services | Teladoc Health, Amwell, Philips - openPR.com
Teladoc Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your RightsTDOC - ACCESS Newswire
Teladoc Health, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsTDOC - ACCESS Newswire
Teladoc health advances virtual mental health with uplift acquisition and integrated solutions - MSN
Teladoc Health: No Real Rescue Insight (NYSE:TDOC) - Seeking Alpha
Teladoc Health Announces Employee Inducement Awards under NYSE R - GuruFocus
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - The Manila Times
Teladoc Strengthens Virtual Care Platform: Awards 267,000 Shares to Uplift Health Acquisition Team and Key Hire - Stock Titan
Teladoc bets $30m that insurance coverage can save BetterHelp - Healthcare Brew
Teladoc Health Acquires Virtual Mental Health Firm UpLift for Over - Hoodline
Surge in Call Options for Teladoc (TDOC) Indicates Bullish Sentiment | TDOC Stock News - GuruFocus
Teladoc call volume above normal and directionally bullish - TipRanks
Teladoc buys virtual mental health startup for $30M to aid struggling therapy business - Crain's New York Business
Teladoc Health, Inc. (NYSE:TDOC) Q1 2025 Earnings Call Transcript - MSN
Teladoc Inc. Earnings Call: Balancing Growth and Challenges - TipRanks
Citi cuts Teladoc price target to $8 from $8.75, keeps Buy rating - Investing.com Nigeria
Teladoc Health (TDOC) Price Target Lowered by Canaccord Genuity - GuruFocus
Teladoc Health, Inc. SEC 10-Q Report - TradingView
Teladoc Health (TDOC) Receives Price Target Adjustment from Gold - GuruFocus
Teladoc Health (TDOC) Receives Price Target Adjustment from Goldman Sachs | TDOC Stock News - GuruFocus
Teladoc Buys UpLift With Eye on Benefits Coverage Model for Mental Health - Healthcare Innovation
Teladoc Health (TDOC): Analyst Lowers Price Target, Maintains Ho - GuruFocus
Teladoc Health (TDOC) Price Target Lowered by Evercore ISI Group - GuruFocus
Teladoc Health (TDOC) Receives Reiterated Rating from Needham | - GuruFocus
Teladoc Health (TDOC) Price Target Lowered by Evercore ISI Group | TDOC Stock News - GuruFocus
Teladoc acquires mental health firm UpLift as BetterHelp earnings slide - Healthcare Dive
Canaccord cuts Teladoc stock target to $12, keeps buy rating - Investing.com
Canaccord cuts Teladoc stock target to $12, keeps buy rating By Investing.com - Investing.com India
Canaccord Adjusts Price Target for Teladoc (TDOC) Following Acqu - GuruFocus
Forecasting The Future: 8 Analyst Projections For Teladoc Health - Benzinga
텔라닥 헬스 (TDOC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):